Bernard Branson is a graduate of Northwestern University Feinberg School of Medicine and completed his postgraduate training at the University of North Carolina, Chapel Hill. He joined the CDC in 1990 and served as Associate Director for Laboratory Diagnostics in the Division of HIV/AIDs. He has been involved with HIV testing for more than 30 years and led the effort to facilitate the introduction of rapid HIV tests into the U.S., served as lead author of CDC’s 2006 revised HIV screening recommendations, and, most recently, was a key participant in the 2014 HIV testing algorithm updates.
At the completion of this educational session, learners will:
- Understand the fundamentals of laboratory tests for COVID-19.
- Appreciate the role for serology tests in identifying exposure to COVID-19.
- Review new developments in HIV tests and their utility for a new diagnostic algorithm.
- Describe how similar parameters affect the accuracy of tests for COVID-19 and HIV.
This CME activity has approved for AMA PRA Category 1 Credit™
for September 23, 2020 as a live activity. This activity will also be available as an enduring activity from September 24, 2020, through September 23,2023.
The target audience is all physicians, NPs and PAs involved or interested in HIV education.
This online video and post-activity evaluation are one hour in length.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™
. Physicians should claim only the credit commensurate with extent of their participation in the activity.
Policies and standards of the Medical Society of the State of New York and the Accreditation Council for Continuing Medical Education require that speakers and planners for continuing medical education activities disclose any relevant financial relationships they may have with commercial interests whose products, devices, or services may be discussed in the content of a CME activity.
- Dr. James F. Braun, DO (Course Director) has no relevant financial relationships to disclose.
- Dr. William M. Valenti (Moderator) has no relevant financial relationships to disclose.
- Dr. Bernard M. Branson (Presenter) has no relevant financial relationships to disclose. Dr. Branson will support his presentation and clinical recommendations with the best available evidence from the medical literature and will submit his slides in advance for adequate peer review.
This PRN CME activity is funded in part by unrestricted educational grants from:
Gilead Sciences; Janssen Therapeutics, a division of Janssen Products, LP; Merck & Co.; and ViiV Healthcare
Click here to take the CME Evaluation and Post-Meeting Evaluation